Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Serine Palmitoyltransferase 2 Antibody Blocking Peptide
SDP

Catalog No. NBP176573E
Click to view available options
Quantity:
0.05 mg

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 15 amino acids near the carboxy terminus of human SPT2. Source: Synthetic (Accession #: NP_004854) The Serine Palmitoyltransferase 2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 9517
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76573. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias EC 2.3.1, EC 2.3.1.50, KIAA0526HSN1C, LCB 2, LCB2a, LCB2NSAN1C, Long chain base biosynthesis protein 2, Long chain base biosynthesis protein 2 A, serine palmitoyltransferase 2, serine palmitoyltransferase, long chain base subunit 2, serine palmitoyltransferase, subunit II, Serine-palmitoyl-CoA transferase 2, SPT 2, SPT2
Gene Symbol SPTLC2
Product Type Serine Palmitoyltransferase 2
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 15 amino acids near the carboxy terminus of human SPT2
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.